Toward an analogue of the transition state of preD3-D3 isomerization: Stereoselective synthesis of linearly fused 6-8-6 carbocyclic systems

Organic Letters

Volumn 4, Issue 10, 2002, Pages 1651-1654

  Codesido, Eva M ^a   Rodríguez, J Ramón ^a   Castedo, Luis ^a   Granja, Juan R ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

COLECALCIFEROL; DRUG DERIVATIVE; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; POLYCYCLIC AROMATIC HYDROCARBON; PREVITAMIN D(3);

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; ISOMERISM; OXIDATION REDUCTION REACTION; STEREOISOMERISM;

CHOLECALCIFEROL; INDICATORS AND REAGENTS; ISOMERISM; MODELS, MOLECULAR; OXIDATION-REDUCTION; POLYCYCLIC HYDROCARBONS, AROMATIC; STEREOISOMERISM;

EID: 0037118326     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol025756c     Document Type: Article

References (47)

1. This paper is partially based on the doctoral thesis of Eva María Codesido, University of Santiago de Compostela, 2001.
2. For reviews, see: (a) Oishi, T.; Ohtsuka, Y. In Studies in Natural Products Synthesis; Atta-ur-Rahman. Ed.; Elsevier: Amsterdam, 1989; Vol. 3, pp 73-115.
3. (b) Petasis, N. A.; Patane, M. A. Tetrahedron 1992, 48, 5757-5821.
4. (c) Rousseau, G. Tetrahedron 1995, 51, 2777-2849.
5. (d) Molander, G. A. Acc. Chem. Res. 1998, 31, 603-609.
6. (e) Mehta, G.; Singh, V. Chem. Rev. 1999, 99, 881-990.
7. Codesido, E. M.; Castedo, L.; Granja, J. R. Org. Lett. 2001, 3, 1483-1486.
8. 5 consists of a thermally induced antarafacial [1,7]-sigmatropic hydrogen shift from C19 to C9. For studies of the mechanism of this physiologically important transformation, see: (a) Havinga, E. Experientia 1973, 29, 1181-1192.
9. (b) Okamura, W. H.; Midland, M. M.; Hammond, M. W.; Rahman, N. A.; Dormanen, M. C.; Nemere, I.; Norman, A. W. J. Steroid Biochem. Mol. Biol. 1995, 53, 603-613.
10. (c) Tian, X. Q.; Holick, M. F. J. Biol. Chem. 1999, 274, 4174-4179.
11. Henry, H. L.; Norman, A. W. Metabolism of Vitamin D. In Disorders of Bone and Mineral Metabolism; Coe, F. L.; Favus, M. J., Eds.; Raven Press: New York, 1991; pp 149-162.
12. The catalytic antibody strategy is a powerful method for the design of enzymes that achieve transformations that are rare or do not occur in nature; see: (a) Schultz, P. G.; Lerner, R. A. Science 1995, 269, 1835-1842.
13. (b) Wentworth, P.; Janda, K. D. Curr. Opin. Chem. Biol. 1998, 2, 138-144.
14. (c) Hilvert, D. Top. Stereochem. 1999, 22, 83-135.
15. 5 are now thought to include promotion of cell differentiation, inhibition of tumor cell proliferation, and induction of functions related to the immunological system. For some studies of the biological activity of this hormone, see: (a) Bouillon, R.; Okamura, W. H.; Norman, A. W. Endocr. Rev. 1995, 16, 200-257.
16. (b) Vitamin D: Chemistry, Biology and Clinical Applications of the Steroid Hormone; Norman, A. W., Bouillon, R., Thomasset, M., Eds.; Vitamin D Workshop, Inc.; Riverside, CA, 1997.
17. 3; see: (a) Norman, A. W.; Okamura, W. H.; Farach-Carson, M. C.; Allewaert, K.; Branisteanu, D.; Nemere, I.; Muralidharan, K. R.; Bouillon, R. J. Biol. Chem. 1993, 268, 13811-13819.
18. (b) Okamura, W. H.; Midland, M. M.; Norman, A. W.; Hammond, M. W.; Rahman, N. A.; Dormanen, M. C.; Nemere, I. Ann. N.Y. Acad. Sci. 1995, 761, 344-348.
19. 3 bearing an eight-membered ring B has been published: Hayashi, R.; Fernández, S. Okamura, W. H. Org. Lett. 2002, 4, 851-854.
20. For reviews of metathesis, see: (a) Fürstner, A. Angew. Chem., In. Ed. 2000, 39, 3012-3043.
21. (b) Chang, S.; Grubbs, R. H. Tetrahedron 1998, 54, 4413-4450. For a recent view of the synthesis of medium-sized rings by RCM, see:
22. (c) Maier, M. E. Angew. Chem., Int. Ed. 2000, 39, 2073-2077 For a more general review of the synthesis of medium-sized rings, see:
23. (d) Yet, L. Chem. Rev. 2000, 100, 2963-3007.
24. For convenience, steroid numbering is used.
25. For recent uses of intramolecular Heck reactions for the construction of 6-7 fused bicyclic systems, see: (a) Lee, K.; Cha, J. K. J. Am. Chem. Soc. 2001, 123, 5590-5591. For recent reviews of this reaction, see:
26. (b) Beletskaya, I. P.; Cheprakov, A. V. Chem. Rev. 2000, 100, 3009-3066.
27. (c) Link J. T.; Overman, L. E. In Metal-Catalyzed Cross-Coupling Reactions; Diederich, F., Stang, P. J., Eds.; Wiley-VCH: Weinheim, 1998; Chapter 6.
28. (d) de Meijere, A.; Meyer, F. E. In Metal-Catalyzed Cross-Coupling Reactions; Diederich, F., Stang, P. J., Eds.; Wiley-VCH: Weinheim, 1998; Chapter 3.
29. (e) Link, J. T.; Overman, L. E. CHEMTECH 1998, 19-26.
30. (f) Neghisi, E.-i.; Coperet, C.; Ma, S.; Liou, S.-Y.; Liu, F. Chem. Rev. 1996, 96, 6, 365-393.
31. Preliminary studies had shown the viability of the Heck cyclization of iododiene 8; see: Codesido, E. M.; Cid, M. M.; Castedo, L.; Mouriño, A.; Granja, J. R. Tetrahedron Lett. 2000, 41, 5861-5864.
32. Mascareńas, J. L.; Sarandeses, L.; Castedo, L.; Mouriño, A. Tetrahedron 1991, 47, 3485-3498.
33. Owczarczyk, Z.; Lamaty, F.; Vawter, E. J.; Neghisi, E.-i. J. Am. Chem. Soc. 1992, 114, 10091-10092.
34. The relative stereochemistry of 4 was determined by NOE experiments as in ref 3.
35. Scholl, M.; Ding, S.; Lee, C. W.; Grubbs, R. H. Org. Lett. 1999, 1, 953-956.
36. Palomo, C.; Oiarbide, M.; Mielgo, A.; González, A.; García, J.; Landa, C.; Lecumberri, A.; Linden, A. Org. Lett. 2001, 3, 3249-3252.
37. The 15a/15b ratio was almost 1:1 after 48 and after 76 h. For an example of stereocontrolled RCM, see: Huwe, C. M.; Velder, J.; Blechert, S. Angew. Chem., Int. Ed. Engl. 1996, 35, 2376-2378.
38. Stork, G.; Zhao, K. Tetrahedron Lett. 1989, 30, 2173-2174.
39. H4-H5 coupling was close to zero.
40. For some examples of stereoselective enol alkylation, see: (a) Hughes, D. L. In Comprehensive Asymmetric Catalysis; Jacobsen, E. N., Pfaltz, A., Yamamoto, H., Eds.; Springer-Verlag: Berlin, 1999; Chapter 34.1. For a review of asymmetric protonation of enolates, see:
41. (b) Yanagisawa, A.; Yamamoto, H. In Comprehensive Asymmetric Catalysis, Jacobsen, E. N., Pfaltz, A., Yamamoto, H., Eds.; Springer-Verlag: Berlin, 1999; Chapter 34.2.
42. For a recent study of the diastereoselectivity of cycloalkanone alkylation, see: (a) Gung, B. W. Chem. Rev. 1999, 99, 1377-1386.
43. (b) Ohwada, T. Chem. Rev. 1999, 99, 1337-1376.
44. For reviews of asymmetric Claisen rearrangement, see: (a) Ito, H.; Taguchi, T. Chem. Soc. Rev. 1999, 28, 43-50.
45. (b) Enders, D.; Knopp, M.; Schiffers, R. Tetrahedron: Asymmetry 1996, 7, 1847-1882. For recent reports of enantioselective catalytic Claisen rearrangement, see:
46. (c) Yoon, T. P.; MacMillan, D. W. C. J. Am. Chem. Soc. 2001, 123, 2911-2912.
47. (d) Abraham, L.; Czerwonka, R.; Hiersemann, M. Angew. Chem., Int. Ed. 2001, 40, 4700-4703.